WallStreetZenWallStreetZen

NASDAQ: ABEO
Abeona Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Abeona Therapeutics earnings were $57.2M for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. The latest ABEO earnings report on Jun 30, 2025 announced Q2 2025 earnings of $108.8M, down 1,004.8% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, ABEO reported annual earnings of -$63.7M, with 17.6% growth.

ABEO earnings history

Current Revenue
$400.0k
Current Earnings
$57.2M
Current Profit Margin
14,310.5%
ABEO's has not demonstrated consistent... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

ABEO Return on Equity

Current Company
77.7%
Current Industry
-9.6%
Current Market
26.6%
ABEO's Return on Equity (77.7%)... subscribe to Premium to read more.
High Return on Equity Performance

ABEO undefined

Current Company
39.8%
Current Industry
0.1%
ABEO is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when ABEO announces earnings.

ABEO undefined

Current Company
36.32%
Current Industry
7.8%
ABEO has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ABEO vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
ABEO$79.97M$57.24MN/A$1.06
FULC-$71.78M-$73.22MN/A-$1.18
INBX-$153.24M-$163.69MN/A-$12.52
ATXS-$116.92M-$116.92MN/A-$2.01
ADCT-$115.26M-$169.94MN/A-$1.55
View Top Biotech Stocks

Abeona Therapeutics Earnings Reports & History FAQ

What were Abeona Therapeutics's earnings last quarter?

On ABEO's earnings call on Invalid Date, Abeona Therapeutics (NASDAQ: ABEO) reported Q2 2025 earnings per share (EPS) of $2.07, up 989.47% year over year. Total ABEO earnings for the quarter were $108.83 million. In the same quarter last year, Abeona Therapeutics's earnings per share (EPS) was $0.19.

If you're new to stock investing, here's how to buy Abeona Therapeutics stock.

Is Abeona Therapeutics profitable or losing money?

As of the last Abeona Therapeutics earnings report, Abeona Therapeutics is currently profitable. Abeona Therapeutics's net profit (also called net income) for the twelve months ending Jun 30, 2025 was $57.24 million, a 208.83% decrease year over year.

What was ABEO's earnings growth in the past year?

As of Abeona Therapeutics's earnings date in Invalid Date, Abeona Therapeutics's earnings has grown year over year. ABEO earnings in the past year totalled $57.24 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.